Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sarepta's Loss Widens 59% as it Prepares Eteplirsen For a New Drug Application Filing
Sarepta's Loss Widens 59% as it Prepares Eteplirsen For a New Drug Application Filing
Sarepta's Loss Widens 59% as it Prepares Eteplirsen For a New Drug Application Filing
Submitted by
admin
on May 8, 2014 - 12:26pm
Source:
Motley Fool
News Tags:
Sarepta Therapeutics
earnings
Headline:
Sarepta's Loss Widens 59% as it Prepares Eteplirsen For a New Drug Application Filing
Do Not Allow Advertisers to Use My Personal information
